Otros efectos secundarios pueden incluir mareos, aumento de la frecuencia cardaca, infecciones, dolores de cabeza e indigestin
In this post, Ill share with you some of the plotline for our discussion
Severe abdominal pain, particularly if it radiates to the back, could indicate pancreatitis, a rare but serious adverse event associated with GLP-1 therapy
HM12525A) is also a unimolecular once weekly GLP-1 and glucagon agonist that has been investigated in people with obesity, T2D and MASLD/MASH
These drugs were initially developed for the treatment and/or management of diabetes, but scientists thought this drug could be a direct cure for obesity as well
Glucagon receptor activation increases hepatic glucose output and energy expenditure, but it also influences bile acid production and gastrointestinal motility